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Abstract: Chronic obstructive pulmonary disease (COPD) is characterized by poorly 
reversible airﬂ  ow limitation. The pathological hallmarks of COPD are inﬂ  ammation of the 
peripheral airways and destruction of lung parenchyma or emphysema. The functional conse-
quences of these abnormalities are expiratory airﬂ  ow limitation and dynamic hyperinﬂ  ation, 
which then increase the elastic load of the respiratory system and decrease the performance 
of the respiratory muscles. These pathophysiologic features contribute signiﬁ  cantly to the 
development of dyspnea, exercise intolerance and ventilatory failure. Several treatments 
may palliate ﬂ  ow limitation, including interventions that modify the respiratory pattern 
(deeper, slower) such as pursed lip breathing, exercise training, oxygen, and some drugs. 
Other therapies are aimed at its amelioration, such as bronchodilators, lung volume reduc-
tion surgery or breathing mixtures of helium and oxygen. Finally some interventions, such 
as inspiratory pressure support, alleviate the threshold load associated to ﬂ  ow limitation. The 
degree of ﬂ  ow limitation can be assessed by certain spirometry indexes, such as vital capacity 
and inspiratory capacity, or by other more complexes indexes such as residual volume/total 
lung capacity or functional residual capacity/total lung capacity. Two of the best methods 
to measure ﬂ  ow limitation are to superimpose a ﬂ  ow–volume loop of a tidal breath within a 
maximum ﬂ  ow–volume curve, or to use negative expiratory pressure technique. Likely this 
method is more accurate and can be used during spontaneous breathing. A deﬁ  nitive deﬁ  nition 
of dynamic hyperinﬂ  ation is lacking in the literature, but serial measurements of inspiratory 
capacity during exercise will document the trend of end-expiratory lung volume and allow 
establishing relationships with other measurements such as dyspnea, respiratory pattern, 
exercise tolerance, and gas exchange.
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Introduction
Chronic obstructive pulmonary disease (COPD) is deﬁ  ned as a disease state characterized 
by poorly reversible airﬂ  ow limitation and loss of pulmonary capillary bed. It is usually 
progressive and associated with abnormal inﬂ  ammatory responses in the lung (Pauwels
et al 2001). Chronic inﬂ  ammation is a predominant feature of COPD and involves 
the airways (Saetta et al 2001), lung parenchyma (Saetta et al 1999), and pulmonary 
vasculature (Peinado et al 1999). It is caused by exposure to inhaled noxious particles 
and gases present in tobacco smoke (Von Essen et al 1995; Salvi et al 1999) and 
likely in other air pollutants that may be inhaled during breathing. Macrophages, 
T lymphocytes (predominately CD8+), and neutrophils are increased numerically as 
well as activated (Pesci et al 1998), this results in the release of a variety of mediators 
(Keatings et al 1996; Mueller et al 1996; Yamamoto et al 1997; Beeh et al 2003) that 
are believed to be capable of unbalance the protease-antiprotease equilibrium (Gottlieb 
et al 1996; Stockley et al 1999) and damage lung structures (Liu et al 1999; Shapiro 
and Senior 1999).
The pathological hallmarks of COPD are inﬂ  ammation of the peripheral airways 
and destruction of lung parenchyma or emphysema (Thurlbeck 1991). The functional 
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consequence of these abnormalities is expiratory airﬂ  ow limi-
tation. Since the determinants of expiratory ﬂ  ow through the 
airways are both the driving alveolar pressure that promotes 
ﬂ  ow (elastic recoil of the lung) and the opposing resistance 
of the airways, the reduction in ﬂ  ow occurring in COPD is 
deﬁ  ned more accurately as airﬂ  ow limitation rather than air-
ﬂ  ow obstruction, since both loss of elastic recoil and increase 
in airway resistance play an important role (Pride and Green 
1997). Emphysema will contribute to the airﬂ  ow limitation 
by reducing the elastic recoil of the lung through parenchymal 
destruction, as well as by reducing the elastic load applied to 
the airways through destruction of alveolar attachments. On 
the other hand, inﬂ  ammation of the peripheral airways will 
contribute to the airﬂ  ow limitation by increasing the thickness 
of the airway wall which, together with ﬁ  brosis and smooth 
muscle hypertrophy, may cause airway narrowing (Thurlbeck 
1985). The role of mucus hypersecretion in the development of 
chronic airﬂ  ow limitation is still controversial (Peto et al 1983; 
Vestbo et al 1996).
Expiratory ﬂ  ow limitation and dynamic hyperinﬂ  ation (DH) 
are clinical and pathologic concepts that have been present for 
well over 100 years. Recent developments have revitalized 
the interest on this crucial psychopathological consequence of 
obstructive disease. In accordance with this renewed interest, 
a provocative hypothesis has been put forward recently that 
proposes that the transition from peripheral airways disease to 
COPD follows three pathophysiological stages deﬁ  ned by the 
severity of expiratory ﬂ  ow limitation: In Stage I, closing volume 
eventually exceeds the functional residual capacity (FRC); in 
Stage II tidal volume expiratory ﬂ  ow limitation (EFL) develops; 
and in Stage III, DH increases to a point that produces dyspnea 
and exercise limitation. The presence of airway closure (Stage 
I) and EFL (Stage II) may promote peripheral airway injury 
and accelerate the abnormalities of lung function (Milic-Emili 
2004).
Pathophysiology of dynamic
hyperinﬂ  ation 
Nonmuscular factors
The respiratory system (ie, the combined elastic recoil of 
the lung and chest wall) is an elastic structure able to change 
its shape and volume in order to breathe the necessary air 
in, and the alveolar gas out, to sustain the amount of gas 
exchange needed to match metabolic needs. Under normal 
physiological conditions the respiratory muscles provide the 
power to produce such changes in volume. For a given change 
in pleural pressure generated by the respiratory muscles, 
the attainable end-inspiratory and end-expiratory volumes 
are determined by the passive pressure–volume (P–V) 
relationship of the respiratory system (Figure 1) (Mead et al 
1967; Agostoni and Hyatt 1986). The P–V behavior of the 
respiratory system is distinctly sigmoid (Figure 1) since the 
respiratory system is most compliant between 20% to 80% 
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Figure 1 Pressure volume relationship of the passive respiratory system. Lower and upper boundaries of the elastic recoil pressure–volume relationship of the respiratory 
system in healthy subjects (---), in patients with narrowed airways (—), and in patients with loss of lung elastic recoil (·····). The loops represent tidal breathing at rest (—) 
and during exercise (·····). 
Abbreviations: FRC, functional residual capacity; VC, vital capacity.International Journal of COPD 2006:1(4) 383
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of the vital capacity (VC) (Mead et al 1967; Agostoni and 
Hyatt 1986). To state this in a clearer way, the elastic work 
of breathing is minimized by maintaining tidal volume within 
the 20%–80% of the VC range. In COPD there are different 
forms and degrees of damage to the alveolar wall resulting in 
pathophysiological changes in the lung elastic recoil. These 
changes might reduce the amount of pressure required to 
achieve a speciﬁ  c change in volume (Cherniack et al 1963; 
Saksena and Burrows 1966), or simply shift the normal 
relationship upwards near passive FRC (Figure 1) (Sharp
et al 1968). There is limited information about passive 
elastic recoil characteristics of the lung and chest wall dur-
ing exercise, but at least in healthy subjects, they remain 
essentially unchanged, or decrease slightly (Stubbing 
et al 1980; Younes and Kivinen 1984). Therefore total lung 
capacity (TLC) does not change signiﬁ  cantly during physi-
cal activity either in normal subjects or in COPD patients 
(Stubbing et al 1980).
While the P–V relationship determines the attainable 
volume extremes for a given muscular pressure, the actual 
volume change in a given amount of inspiratory or expira-
tory time depends on the pressure–ﬂ  ow (P–F) relationship, 
which is highly dependent on the airways resistance (in a 
linear system, the volume at the time tx [Vtx] is given by 
the expression 
Vtx = P·C·(1–e-tx/RC) 
where P is the pressure applied, C the compliance of the 
system, tx the time elapsed, and R the resistance. The prod-
uct RC is the time constant, which determines the speed of 
the change), as can be seen in Figure 2. During inspiration, 
even when inspiratory resistances are high, ﬂ  ow down the 
airways can be increased by increasing the force of inspiratory 
muscle contraction up to its maximum capacity (Younes and 
Riddle 1981). The same is true during expiration at relative 
low pressures, but during forced expiration in both normal 
and COPD, increments in alveolar pressure (generated by 
increasing muscle effort) produce progressively smaller 
increments in expiratory ﬂ  ow, until ﬂ  ow ultimately reaches 
a plateau (Figure 3) where it is independent of any increase 
of driving pressure (Hyatt and Wilcox 1963). This phenom-
enon is called ﬂ  ow limitation and it seems to be related to 
the dynamic compression of the intra-thoracic airways at a 
segment progressively distal as lung volume decreases (Green 
and Pride 1997). The resulting increase in airways resistance 
offsets the pressure generated by the additional increase in 
muscular effort, and therefore expiratory ﬂ  ow is actually 
Figure 2 Effects of time and resistance on the change in expiratory volume. Rates of changes of volume after a similar given change of alveolar pressure in a subject with 
normal respiratory system resistance (—) and a resistance 3 times greater (---) such as in COPD, assuming a constant compliance. Note the marked effect of resistance on 
the volume change, particularly when the available time is shortened.
Abbreviations: COPD, chronic obstructive pulmonary disease. 
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Figure 3 Iso-volume pressure-ﬂ  ow relationship. Schematic representation of the pressure-ﬂ  ow relationship in a healthy (normal) subject and a patient with COPD, showing 
the effect of the increased expiratory resistance upon the maximum expiratory ﬂ  ow and in both cases the independence of the maximum ﬂ  ow from the pleural pressure. 
Copyright © 1986. Modiﬁ  ed with permission from Pride NB, Macklem PT. 1986. Lung mechanics in disease. In: Fishman AP (ed). Handbook of physiology, Section 3, Volume III, 
Part 2: The respiratory system. Bethesda MD: American Physiological Society, pp 659–92. 
Abbreviations: COPD, chronic obstructive pulmonary disease.
largely independent of muscle effort and is determined by 
the respiratory system elastic recoil. Elastic recoil of the 
system is proportional to lung volume and the expiratory 
airways conductance (ie, the inverse of resistance) (Hyatt 
1983). Respiratory mechanics in COPD are characterized by 
both elevated inspiratory and expiratory resistance to airﬂ  ow 
(McGregor and Becklake 1961; Citterio 1981; Aldrich et al 
1989). An increased inspiratory airﬂ  ow resistance can be 
compensated by augmenting the activation of the inspira-
tory muscles (Im Hof et al 1986), but the increased expira-
tory resistance, together with the reduced lung elastic recoil 
present in these patients, further limits expiratory ﬂ  ow (Hyatt 
1961). This is physiologically much more deleterious because 
expiration is primarily effort independent (Figure 3), and can-
not be compensated by increasing expiratory muscle effort 
(Poon et al 1987). The consequence in COPD is that the time 
needed for lung units to empty their volume and achieve their 
passive equilibrium point is signiﬁ  cantly increased and many 
of them do not reach their relaxation volume before a new 
inspiration is initiated. As a result, part of the gas that would 
have been expired in a normal lung remains “ trapped” (ie, 
more gas remains inside that what would be if those units 
were not altered) and the alveolar pressure at the end of the 
expiration is higher than the atmospheric pressure (intrinsic 
PEEP) (Pride and Macklem 1986; Younes 1991). In young 
healthy subjects RV is about 25% of the TLC, and FRC is 
about 50% of the TLC (Stocks and Quanjer 1995). In older 
healthy subjects, RV and FRC are about 30% and 55% of 
TLC respectively (Stocks and Quanjer 1995). In COPD, 
values of RV and FRC are increased to values as high 
as 70% and 85% of the TLC, respectively (Fishman et al 
2003). Since tidal breathing is performed at FRC, COPD 
must breathe at volumes that are very close to TLC where 
the system is much less distensible (Figure 1). 
During exercise minute ventilation must increase to meet 
the increased metabolic demands. This is achieved by increas-
ing both the tidal volume (VT) and the respiratory frequency 
(fR), what means that the expiratory time necessary to reach 
passive FRC or below is reduced. In normal young subjects 
expiratory ﬂ  ow is fast enough to decrease end-expiratory 
lung volume (EELV) up to 0.5–1L below the resting FRC 
with increasing work. This is due to the activation of ex-
piratory muscles (Pride and Macklem 1986; Henke et al 
1988). The decreased EELV not only allows increasing 
VT within the most compliant part of the P–V relationship, 
but also has a beneﬁ  cial inspiratory effect because, as the 
expiratory muscles relax, the passive tendency of the res-
piratory system below FRC is towards inspiration. In older 
subjects, EELV also decreases during moderate exercise, 
but thereafter, tends to increase back to near resting levels 
(Johnson et al 1991). In COPD, due to the increased ﬂ  ow 
limitation, more and more units are unable to empty their 
gas as expiratory time decreases when the respiratory rate 
increases, and EELV typically rises (Figures 1 and 4) (Hyatt International Journal of COPD 2006:1(4) 385
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1961; Grimby et al 1968; Potter et al 1971; Dodd et al 1984; 
Pride and Macklem 1986; Babb et al 1991; Younes 1991; 
Yan et al 1997; Diaz et al 2000; O’Donell et al 2001; Oga 
et al 2002, 2003; O’Donnell and Webb 2003; Puente-Maestu 
et al 2005) in spite of expiratory muscles activity (Dodd et al 
1984; Younes 1991). This temporary increase in EELV in 
COPD above its baseline (admittedly already elevated) value 
is termed DH. The extent of DH depends on the degree of 
expiratory ﬂ  ow limitation, the prevailing ventilation, the 
breathing pattern for a given ventilation, and is inversely 
related to the level of resting lung hyperinﬂ  ation (O’Donnell 
et al 2001; Puente-Maestu et al 2005).
Muscle function
To move the air into the alveoli, sufﬁ  cient force must be 
exerted by the respiratory muscles to expand the lungs and 
the chest wall. In addition, respiratory muscles must over-
come the resistance and inertia in the system so that air will 
ﬂ  ow into the airways. This force is provided by the respira-
tory muscles and, thus, breathing is the results of their cyclic 
activation. Whether the net force is inspiratory or expiratory 
will depend on the balance between the pressure generated by 
the muscles and the elastic recoil of the respiratory system. 
The maximum inspiratory and expiratory pressures that the 
respiratory muscles are able to generate are related to several 
factors such as age (Black and Hyatt 1969), muscle training 
(Leith and Bradley 1976), the integrity of the inervation (Gross 
et al 1980) and, more important for the present discussion, of 
the length and shape (usually termed as “configuration”) of 
the respiratory muscles, and particularly of the diaphragm 
(Marshall 1962). According to the Laplace’s relationship (the 
Laplace relationship establishes the relationship between the 
pressure generated across a curved surface “P”, the tension of 
the surface “T” and its radius “r”: P = T/r), the less curved a 
surface is, the lower the pressure difference created across it. 
Thus at high lung volumes, a given neural output would be 
likely to cause less change in trans-diaphragmatic pressure 
than at low lung volumes. Furthermore, inspiratory muscles 
are able to generate less pressure for a given neural input 
because of their length–tension relationship (Kim et al 1976; 
Similowski et al 1991; Polkey et al 1998). The ability of the 
respiratory muscles to sustain a given level of pressure out-
put (endurance) is deﬁ  ned by its pressure time index (PTI)
(McGregor and Becklake 1961; Bellee and Grassino 1982, 1983)
  PTI = (Pimus/MIP)  ×  (Ti/Ttot) × 100   (1)
Where “Pimus” is the inspiratory muscular pressure needed 
to achieve a certain displacement of the respiratory system, 
“MIP” is the maximum inspiratory pressure, “Ti” the 
inspiratory time and “Ttot” the total respiratory time. Thus 
the PTI is determined to a considerable degree by how high 
MIP is, and the fraction of MIP required to sustaining a given 
VT. MIP decreases as lung volume increases, while maximum 
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Figure 4 Maximum and tidal ﬂ  ow-volume curves in subjects with and without ﬂ  ow limitation. In this ﬁ  gure it can be seen an schematic representation of the spontaneous 
ﬂ  ow-volume curves generated at tidal volume at rest (inner dotted line ····) and peak exercise (dashed line ----) compared with the maximum ﬂ  ow volume curve in a 
subject without ﬂ  ow limitation able to reduce its end-expiratory lung volume (Panel A) and a ﬂ  ow-limited COPD patient with dynamic hyperinﬂ  ation (Panel B). 
Abbreviations: COPD, chronic obstructive pulmonary disease; IC, inspiratory capacity. International Journal of COPD 2006:1(4) 386
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Table 1 Main clinical consequences of dynamic hyperinﬂ  ation
Exercise limitation and dyspnea
Hypoventilation during exercise
Hypercarbic respiratory failure during exacerbations
Hypercapnia during exercise
Cardiac dysfunction during exercise
Weaning failure
Hypotension and barotraumas during mechanical ventilation
Independent risk factor for survival in COPD subjects
Reduced improvement with exercise training
expiratory pressure changes in the opposite direction (Agostoni 
and Hyatt 1986), therefore at high volumes a greater fraction 
of maximum effort is required to generate the same pressure. 
Paradoxically, thus, while ﬂ  ow limitation is primarily an ex-
piratory phenomenon, its consequences are mainly suffered 
by the inspiratory muscles because expiratory muscles can-
not appreciably increase ﬂ  ow (Figures 3) (Hyatt 1961, 1983; 
Hyatt and Wilcox 1963; Pride and Macklem 1986; Green and 
Pride 1997) to force the emptying of the lungs. In consequence 
the volume at which the respiratory system has to operate is 
increased (Hyatt 1961; Grimby et al 1968; Potter et al 1971; 
Dodd et al 1984; Pride and Macklem 1986; Babb et al 1991; 
Younes 1991; Yan et al 1997; Diaz et al 2000; O’Donnell et al 
2001; Oga et al 2002, 2003; O’Donnell and Webb 2003; Puente-
Maestu et al 2005) and hence the elastic work needed for a given 
displacement of the thorax (Figure 1 and 4) (Cherniack et al 
1963; Saksena and Burrows 1966; Mead et al 1967; Sharp et al 
1968; Younes and Kivinen 1984; Agostoni and Hyatt 1986). 
Second inspiratory muscles have to generate a substantial in-
spiratory pressure (intrinsic PEEP) before inspiratory airﬂ  ow 
can occur. PEEP behaves actually as an inspiratory threshold 
load (Pepe and Marini 1982; Pride and Macklem 1986; Haluszka 
et al 1990; Younes 1991), and ﬁ  nally, as we have seen above, 
at high lung volume efﬁ  cacy of respiratory muscles as pressure 
generators is greatly reduced (Marshall 1962; Kim et al 1976; 
Similowski et al 1991; Polkey et al 1998).
Clinical consequences of dynamic 
hyperinﬂ  ation
Exercise limitation
Patients with COPD characteristically show a poor exercise 
performance which is manifested as marked reduction in 
peak oxygen uptake and decreased endurance to submaximal 
levels of exercise (Table 1) (Gallagher 1994; Casaburi et al 
1999; O’Donnell and Webb 2003). The origin of this poor 
exercise tolerance is multifactorial and includes abnormal lung 
mechanics, impaired pulmonary gas exchange, destruction of 
the pulmonary vascular bed, impaired cardiac function and 
peripheral muscle dysfunction (Gallagher 1994; Casaburi 
et al 1999; O’Donnell and Webb 2003). Dynamic hyper-
inﬂ  ation has a detrimental impact on exercise tolerance via 
three important physiopathological mechanisms. The rela-
tively rapid shallow breathing pattern in COPD compared 
with healthy subjects, reﬂ  ects the mechanical constraints 
on tidal volume expansion, which has an exaggerated 
frequency-dependency in COPD, fR increases with exercise 
in COPD up to a maximum of about 25–35min-1 (Diaz 
et al 2000; Nield et al 2003; Puente-Maestu et al 2005). 
At increased respiratory rates, the inversely proportional 
decrease in expiratory time, even though there is a slight 
reduction of Ti/Ttot to 0.40–0.45 (Diaz et al 2000; Puente-
Maestu et al 2005), and as result of the decreased expiratory 
time further DH ensues. When EELV reaches approximately 
0.5L tidal volume, ventilation reaches a plateau (or even a 
slight decreases), exercise soon stops (Figure 5) (O’Donnell 
et al 2001; Puente-Maestu et al 2005). This encroachment 
of tidal volume not only hampers the ventilatory response to 
the metabolic load of exercise, it contributes to reducing the 
efﬁ  ciency of ventilation (ie, increases the dead space) as well 
(Gallagher 1994). This effect, together with the augmented 
mechanical impedance of the respiratory system results in 
an increased work and O2 cost of breathing at any given 
metabolic load compared with age-matched healthy controls, 
(Roussos et al 1982; Donahoe et al 1989; Shindoh et al 1994; 
Mannix et al 1999; Takayama et al 2003). In one study this 
additional oxygen cost has been found to be as much as 40% 
of the total oxygen uptake (Levison and Cherniack 1968). 
Dyspnea
Dyspnea is believed to be the unpleasant awareness of the 
respiratory muscle effort. As it was discussed above DH both 
increases the pressure changes needed to achieve a given tidal 
volume and decreases the ability of the respiratory muscles 
to generate this pressure (Marshall 1962; Kim et al 1976; 
Similowski et al 1991; Polkey et al 1998). This then increases 
the amount of pressure needed to achieve a certain tidal volume 
with respect to the maximum pressure (Killian et al 1992). The 
change in lung mechanics during exacerbation of COPD has 
been show to be directly related to dyspnea during spontane-
ously breathing. The improvement in operating lung volumes 
(ie, increase in inspiratory capacity [IC]) as the exacerbation International Journal of COPD 2006:1(4) 387
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resolves is correlated to symptomatic improvement and 
reductions in dyspnea (Parker et al 2005; Stevenson et al 
2005). While COPD patients do not usually stop exercise 
at higher rates of perceived dyspnea than normal subjects, 
the ratio of symptoms to the metabolic load and minute 
ventilation are usually increased (Killian and Jones 1994; 
Hamilton et al 1996). In these patients there exists a close 
correlation between breathlessness during exercise and DH 
(O’Donnell et al 1993; Eltayara et al 1996; Puente-Maestu et 
al 2005; Vogiatzis et al 2005). In a recent study, arm exercise 
in COPD has been found to produce DH as well (Gigliotti 
et al 2005).
Hypoventilation/hypercapnia
The increase in inspiratory and expiratory airway resistance 
characteristic of COPD would cause only minor problems 
in ventilatory function (ie, for the respiratory muscles) if 
the disease, through expiratory ﬂ  ow limitation did not cause 
dynamic hyperventilation, and its corollaries that include 
increased elastic recoil, encroached tidal volume, the thresh-
old load imposed by intrinsic PEEP, and the changes in the 
conﬁ  guration of the thorax that greatly reduce their ability 
to generate pressure. When COPD patients with expiratory 
ﬂ  ow-limitation need to increase their respiratory rate to 
increase minute ventilation, there is potential for inspiratory 
muscle failure due to DH (Table 1). During exacerbations, 
the inﬂ  ammatory process, the ventilation/perfusion (V’A/Q’) 
mismatching, increased airﬂ  ow resistance, and DH, expose 
the respiratory muscles to the risk of fatigue, eventually 
leading to ventilatory pump failure and hypercapnia (Rossi 
et al 1997). DH is one of the major mechanisms involved 
in the development of hypercapnia and (secondarily hypox-
emia) during exercise in COPD patients (Diaz et al 2000; 
O’Donnell et al 2002).
Cardiac dysfunction
Lung hyperinﬂ  ation and excessive expiratory muscle recruit-
ment can impair venous return and reduce right ventricular 
preload in COPD (Mahler et al 1984; Miller, Pegelow, et al 
2005). Moreover, large intrathoracic pressure swings gener-
ated during exercise to overcome the increased elastic and 
resistive loads may result in left ventricular dysfunction 
(increased left ventricular afterload) (Oswald-Mammosser 
et al 1991; Montes de Oca et al 1996). Right ventricular 
afterload during exercise is also increased because of the 
increased pulmonary vascular resistance associated with 
breathing at lung volumes close to TLC (Ranieri et al 1996; 
Oswald-Mammosser et al 1998). 
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Figure 5 Tidal volume encroachment by dynamic hyperinﬂ  ation in COPD. In this ﬁ  gure the effects of respiratory rate and work rate on the end-inspiratory (EILV), 
end-expiratory lung volume (EELV), tidal volume (ie, EILV–EELV) and minute ventilation in subjects with severe COPD is displayed. While EILV increases with increasing 
respiratory rate from 20 to 30min-1 (lower left panel), so does EELV resulting in an almost constant (encroached) tidal volume. At respiratory rates higher than 30, though, 
EILV does not increase any more , however, EELV further increases resulting in a reduced tidal volume and even a drop in ventilation (left upper panel) at respiratory rates 
higher than 35min-1. In the right lower panel we can see how during progressive exercise tidal volume also decreases at high intensity due again to increase in EELV without 
parallel increase in EILV (Constructed with data from Puente-Maestu et al 2005).
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Weaning failure
The incidence of EFL was very high in a small sample of 
patients with COPD receiving invasive mechanical ventila-
tion for acute respiratory failure. In this series IC was lower in 
patients who failed weaning than those who were successfully 
weaned (Alvisi et al 2003).
Hypotension and barotrauma in the 
mechanical ventilated patient
Dynamic hyperinﬂ  ation is a potential cause of hypotension 
and barotrauma in mechanically ventilated patients with EFLs 
(Table 1). DH should be minimized by the use of bronchodila-
tors and appropriately setting minute ventilation (higher tidal 
volumes, slower respiratory rate, higher I:E ratio) to maximize 
expiratory time (Schumaker et al 2004).
Exercise training
Most rehabilitation programs are based on constant-load 
exercise (CLE) training, consisting of sustained exercise for 
30–40min (ACCP/AACVPR 1997). Generally, high-intensity 
training is argued to be needed for the improvement of exer-
cise capacity (Casaburi et al 2001). Although patients with 
moderately severe COPD (mean forced expiratory volume in 
one second [FEV1] >45% predicted) can tolerate high levels 
(80%) of their peak tolerance for several minutes (Neder 
et al 2000), more severe disease (FEV1 <45% predicted) 
are unable to tolerate such high exercise intensities for long 
periods of time (Maltais et al 1997). Together with periph-
eral muscle dysfunction, the major factor that limit exercise 
tolerance in these patients is the development of DH, and 
the concurrent mechanical constraints on ventilation that 
contribute importantly to perceived respiratory discomfort 
(Diaz et al 2000; Puente-Maestu et al 2005). Dynamic 
hyperventilation is evident even with short exercise bouts 
in interval training (Vogiatzis et al 2004). In one study, 
a correlation was found between resting hyperinflation 
(measured as RV/TLC%) and the increase in endurance time 
after 8 weeks of leg muscle rehabilitation (Puente-Maestu 
et al 2003). In another study, IC was found as a signiﬁ  cant 
predictor of the long term effects after a rehabilitation pro-
gram, but in a multiple logistic regression model, only pres-
sure of carbon dioxide (PaCO2) was identiﬁ  ed as predictor 
for the maintenance of improvement in health-related quality 
of life over one year (Nishiyama et al 2005).
Survival
Certain variables closely linked to DH (O’Donnell et al 
1993, 2001, 2002; Diaz et al 2000; Marin et al 2001) such 
as exercise capacity (maximal oxygen uptake) (Gerardi et al 
1996; Bowen et al 2000; Myers et al 2002; Hiraga et al 2003; 
Oga et al 2003) or 6 minute walking distance (Pinto-Plata 
et al 2004), dyspnea (Celli et al 2004), and oxygen desatura-
tion (Nishimura et al 2002; Hiraga et al 2003; Tojo et al 2005) 
during exercise have been show to be powerful predictors of 
survival in COPD patients (Table 1). A recent study of 689 
COPD patients, with a mean follow up of 34 month, showed 
that the IC/TLC was an independent risk factor for mortality 
in subjects with COPD (Casanova et al 2005). Using the cri-
terion of IC/TLC <25% with a mean follow up period of 34 
months, the adjusted hazard ratio for death of any cause was 
1.97 and 2.04 for death caused by acute respiratory failure 
(Casanova et al 2005). In another study RV/TLC was also 
a prognostic factor for survival at 5 years but not independ-
ent of age, FEV1, and arterial oxygen pressure at maximal 
exercise (Tojo et al 2005).
Therapeutic interventions
directed to ameliorate dynamic 
hyperinﬂ  ation
The treatment of ﬂ  ow limitation and DH has a long history 
that goes back as far as the 19th century, but the recent rec-
ognition of the importance of DH has modiﬁ  ed the target 
physiological variables that we use to evaluate the therapeutic 
interventions, such as bronchodilators or rehabilitation, and 
has led to a renewed interest in speciﬁ  c treatments such as 
the lung volume reduction surgery (LVRS). In this section 
we will discuss those therapies grouped according their target 
physiological variable.
Treatments that primarily
decrease respiratory rate and 
increase VT
Pursed-lip breathing
Pursed-lip breathing (PLB) (Barach et al 1995) is aimed 
to reduce breathing frequency and to diminish the impact 
of intrinsic PEEP on respiratory muscles. PLB produces a 
substantial increase in VT along with a reduced ventilatory 
rate and minute ventilation (Thoman et al 1966; Mueller 
et al 1970; Bianchi et al 2004). There is a direct relationship 
between the efﬁ  cacy of PLB in reducing dyspnea and the 
effect on respiratory rate (Mueller et al 1970). This tech-
nique is able to increase expiratory airways pressure thus 
inhibiting expiratory airways collapse (Ingram et al 1967). It 
appears that patients that do not adopt PLB instinctively did International Journal of COPD 2006:1(4) 389
Hyperinﬂ  ation in COPD
not assume it naturally for long periods of time even when 
properly taught (Tiep et al 1986). In a recent study imposed 
PLB did not improved 6 minute-walking distance, but im-
proved the rate of dyspnea recovery to basal levels (Garrod 
et al 2005). In another study, PLB reduced respiratory rate in 
patients with COPD during exercise on a cycle-ergometer, 
but the effect of imposed PLB on dyspnea were variable and 
related to the change that it promoted in the tidal volume and 
EELV (Spahija et al 2005).
Peripheral muscle training
A number of studies have shown that leg training decreases 
respiratory rate during exercise (Cassaburi et al 1997; Puente-
Maestu et al 2000; Vogiatzis et al 2002; Gigliotti et al 2003; 
Ruiz de Oña et al 2004), and three previous studies have 
directly analyzed the impact of leg training on DH at high 
intensity exercise. In two uncontrolled studies, a reduction 
of respiratory rate and an increase in IC was seen (Gigliotti 
et al 2003; Porszasz et al 2005). In another controlled study, 
the same effect was seen after 8 weeks of leg training on a 
bike compared with no training in moderate to severe COPD 
(Puente-Maestu et al 2006). In another study the opposite was 
observed (Pellegrino 1999). However, this latter study included 
eight quite unusual COPD subjects (ie, 38 [11] years, FEV1 3.5 
(0.5) L and V O2 2.86 (0.6) L min-1) that can not be regarded 
as a typical population of COPD patients. Arm training also 
reduced DH during arm exercise in a small uncontrolled 
study of COPD subjects (Gigliotti et al 2005).
Oxygen
Several observations in nonhypoxemic COPD patients dem-
onstrate the favorable effect of oxygen supplementation dur-
ing exercise in COPD patients without clinically signiﬁ  cant 
hypoxemia (Woodcock, Gross, Geddes, et al 1981; Dean et al 
1992; O’Donnell, Bain, et al 1997). Endurance time increased 
with supplemental oxygen at several different inhaled concen-
trations of oxygen both in a small group (10) of severe mildly 
hypoxemic COPD patients and 7 healthy controls. In both 
groups oxygen reduced fR, dyspnea, and increased VT, and 
endurance time in a dose-dependent fashion, but the effects 
were relatively larger in the COPD patients. In the healthy 
subjects, differences were only appreciable with FIO2 > 0.5 
or more. The improvement in endurance time was correlated 
with a decrease in EELV (Somfay et al 2001). In a group of 
18 severe COPD patients, oxygen reduced the degree of DH 
during recovery from exercise but did not reduce breathless-
ness compared with air, which suggests that lung mechanics 
may play a different role in the genesis of dyspnea during 
recovery from exercise (Stevenson et al 2004).
Opioids
Opioids have been show to decrease dyspnea during exercise 
(Woodcock, Gross, Gellert, et al 1981; Light et al 1989), but 
to our knowledge no study has addressed their effect on DH. 
One study reported a decrease in fR for a given work-rate, 
and increases in VT and ventilation were found (Light et al 
1996). The reported side-effects of opioids and their ten-
dency to lead to tolerance and addiction preclude their use 
except in highly speciﬁ  c cases and end-of-life situations. 
Benzodiazepines do not seem to improve exercise capacity 
or dyspnea (Haas et al 1993) and have a deleterious effect 
on inspiratory muscle function, reducing both VT and minute 
ventilation (Jolly et al 1996).
Treatments that primarily reduce 
ﬂ  ow limitation
One of the most exciting aspects of the renewed inter-
est in DH is the realization that bronchodilator drugs may 
signiﬁ  cantly improve DH, and thus exercise tolerance (Belman 
et al 1996; O’Donnell et al 1998), and that these changes 
may not be detectable by isolated resting pulmonary func-
tion test (PFT) measurements like the FEV1 (Hadcroft and 
Calverley 2001).
Bronchodilators
Several studies have addressed the effect of bronchodilators on 
lung hyperinﬂ  ation (Table 2). In 13 COPD patients randomly 
assigned to receive either inhaled placebo or salbutamol, the 
bronchodilator caused signiﬁ  cant increase in both FEV1 and 
forced vital capacity (FVC). There was also a signiﬁ  cant 
reduction in the peak exercise EELV/TLC and esophageal 
inspiratory pressure/peak inspiratory esophageal pressure. 
Moreover a signiﬁ  cant reduction in breathlessness that cor-
related with changes in end-inspiratory lung volume/TLC 
was also seen (Belman et al 1996). In a retrospective review 
of 281 patients with TLC >133% predicted and 676 with TLC 
between 115% to 133% predicted, 200μg of salbutamol pro-
duced a signiﬁ  cant reduction of FRC, RV, and increased the 
IC and FVC. The FEV1 improved in only a minority (around 
30%). If lung volume measurements are also considered, the 
overall bronchodilator response may improve up to 76% of 
the severely hyperinﬂ  ated group and up to 62% of the mod-
erately hyperinﬂ  ated ones. Changes in volumes correlated 
poorly with changes in maximal airﬂ  ows. Surprisingly TLC 
was also slightly reduced (about 2.5%) by bronchodilators International Journal of COPD 2006:1(4) 390
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suggesting that the changes in airways resistance or the 
familiarity with the method may have affected the constant 
volume plethysmographic technique used to measure vol-
umes (Newton et al 2002). Unless salbutamol had produced 
changes in the ability to generate force by the respiratory 
muscles, or the elastic properties of the lung, both of which 
it are unlikely. Ramirez-Venegas and colleagues (1997) 
found that the use of salmeterol reduced not only dyspnea 
but improved lung function in patients with COPD. Patients 
showed an increase in FVC, a reduction in RV and FRC, and 
no changes in TLC following inhalation of salmeterol. Boni 
and colleagues (2002) studied 20 COPD, 11 with ﬂ  ow limita-
tion using the negative expiratory pressure before and after 
the inhalation of 400μg salbutamol. Following salbutamol, 
IC did not change in non-ﬂ  ow limited patients but increased 
signiﬁ  cantly in the ﬂ  ow-limited ones. Dyspnea decreased 
in relation to IC at rest even in the absence of a signiﬁ  cant 
improvement in FEV1. Di Marco and colleagues (1993) found 
that in patients with decreased baseline inspiratory capaci-
ties; there was a much greater increase of IC after admin-
istration of bronchodilators such as salbutamol, formoterol, 
salmeterol, and oxitropium. This increase correlated closely 
with improvement in a sensation of dyspnea. Celli and col-
leagues (2003) evaluated the long-term effects (4 weeks) of 
18μg/day of tiotropium. Signiﬁ  cant similar improvements in 
the area under the curve of FEV1 and IC and over the curve 
in FRC were observed, reﬂ  ecting sustained improvements in 
hyperinﬂ  ation. O’Donnell, Fluge, and colleagues (2004) and 
Maltais and colleagues (2005) conducted a multicentric study 
on the long-term effects (6 weeks) of 18μg/day of tiotropium. 
Tiotropium reduced lung hyperinﬂ  ation indices at rest and 
during exercise, and improved exercise tolerance 8 h after 
the inhalation of the drug. Finally O’Donnell, Voduc, and 
colleagues (2004) studied the effects of 50μg of inhaled sal-
meterol. After salmeterol versus placebo at rest, IC increased 
and FRC decreased at a standardized time during exercise. 
In addition, IC and VT increased and dyspnea decreased. 
Signiﬁ  cant increments in peak ventilation, oxygen uptake, 
and the duration of the incremental test were also seen. Man 
and colleagues (2004) studied 16 patients with “irreversible” 
severe COPD after two weeks of treatment with 50μg of 
salmeterol twice a day. Salmeterol signiﬁ  cantly reduced the 
transdiaphragmatic pressure-time product, DH, and Borg 
scores during endurance treadmill walk, however there was 
no signiﬁ  cant change in exercise endurance time. 
In contrast with the results of Table 2, bronchodilators 
have shown wide variations in regards to changes in exercise 
capacity (Liesker et al 2002). Earlier negative studies may have 
included subjects whose exercise capacity was not ventilatory-
limited. In fact, several studies in Table 2 demonstrate that the 
effects of bronchodilators are larger in those with ﬂ  ow limita-
tion than in those without ﬂ  ow limitation. Flow limitations are 
a major determinant of exercise capacity (Diaz et al 2000). 
Alternatively, they may have included a great proportion of 
patients that were not responsive to bronchodilators (about 
1/3 of COPD patients do not improve either FEV1 or IC with 
bronchodilators) (Newton et al 2002). Third, some of those 
studies may have used insufﬁ  cient doses and only a few in-
cluded long-acting bronchodilators, and in particular, none 
included tiotropium (Liesker et al 2002). Fourth, most studies 
included 6 minute walking tests to measure exercise capacity; 
however, 6 minute walking distance is sensitive to a learn-
ing effect. Two training sessions are necessary to eliminate 
a learning effect in walking tests (Kervio et al 2003; Knox 
et al 1988). Constant work load tests appears to be more ap-
propriate than other tests, as they allow for placebo-controlled 
comparisons of symptoms and physiological parameters, 
including exercise endurance time at a standardized work 
rate or power output (O’Donnell, Fluge, et al 2004). Cycle 
exercise endurance testing, combined with measurements of 
exertional dyspnea, ventilation, and dynamic operating lung 
volumes, has been shown to be reliable, reproducible, and 
responsive to the intervention (Oga et al 2000; Puente-Maestu 
et al 2003; O’Donnell, Fluge, et al 2004).
Heliox
Helium is gas that is less dense and more viscous than air. Its 
lower density can decrease airway resistance in the absence 
of any anatomical change. Therefore, the greatest theoretical 
beneﬁ  t of heliox would be achieved by decreasing turbulent 
ﬂ  ow in large airways and at branch points in the tracheobron-
chial tree. 
Heliox is unlikely to be of substantial beneﬁ  t in adults 
with asthma. A systematic analysis pooled results from seven 
trials enrolling nearly 400 patients and found no signiﬁ  cant 
improvement in recovery of pulmonary function in patients 
with acute asthma who were treated with heliox (Rodrigo 
et al 2001, 2003). One study examined the effects of heliox 
(80:20) on gas exchange, breathing pattern, respiratory me-
chanics, and gas distribution in patients with stable, but se-
vere, COPD (Swidwa et al 1985). Heliox was not associated 
with signiﬁ  cant changes in minute ventilation or breathing 
pattern, however a 15% reduction in FRC which increased 
back to baseline after a return to air breathing was observed. International Journal of COPD 2006:1(4) 392
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On the other hand another small trial found no change in 
DH among COPD patients (Pecchiari et al 2004). In addi-
tion, the high cost and limited availability of heliox make 
its clinical use more difﬁ  cult. In another study, researchers 
used an esophageal balloon in recently extubated patients 
without signiﬁ  cant lung disease to quantify intrathoracic 
pressure swings and estimate the work of breathing (Jaber 
et al 2001). Fifteen of 18 patients exhibited a drop in their 
work of breathing, although gas exchange parameters were 
unchanged. The patients also reported decreased dyspnea 
while breathing heliox.
The clinical effects of heliox in the absence of positive 
pressure ventilation have not been well studied. Fifty nor-
moxic COPD with an acute exacerbations were prospectively 
randomized in the emergency room to receive either heliox 
(70:30), or air as the driving gas for updraft nebulization of 
a mixture of salbutamol and ipratropium bromide The base-
line FEV1 was 44% There were no signiﬁ  cant differences in 
the change of FEV1 between the two groups by either the 1 
h or 2 h time point. Lung volume measurements were not 
made, but the improvement in forced expiratory ﬂ  ow over 
the middle half of the FVC (FEF25%–75%) was signiﬁ  cantly 
greater in the heliox group, the authors considered that this 
improvement had no clinical signiﬁ  cance, but measures of 
dyspnea or recovery were not provided (deBoisblanc et al 
2000). A retrospective review of 81 patients presenting to the 
emergency department with COPD and hypercarbic respira-
tory insufﬁ  ciency found a signiﬁ  cant reduction in the rates 
of intubation (8% vs 50%) and in-hospital mortality (3% vs 
24%) in the patients who received heliox as compared with 
control patients (Gerbeaux et al 2001).
Several trials have compared noninvasive positive pres-
sure ventilation (NPPV) combined with either air or heliox in 
patients with exacerbations of COPD. In one well-designed 
trial, patients with acute exacerbations of COPD were treated 
with low or high pressure NPPV in combination with heliox 
or oxygen-supplemented air (Jaber et al 2000). Differences in 
breathing pattern, work of breathing, and gas exchange were 
measured in nine patients using an esophageal balloon tech-
nique. Heliox was not associated with changes in breathing 
pattern, whereas high pressure NPPV produced signiﬁ  cant 
increases in tidal volume and minute ventilation. Heliox was 
associated with a reduction in PaCO2 and improvement in all 
measured indices of respiratory effort and work. The beneﬁ  -
cial effects on the measured variables were further increased 
when high pressure NPPV was combined with heliox, com-
pared with the low pressure/air group. The authors suggest 
that the addition of heliox to NPPV may allow a larger 
number of patients to beneﬁ  t from NPPV. In addition, heliox 
may allow the use of lower levels of pressure support, which 
could reduce complications and patient discomfort result-
ing from high pressures and ﬂ  ow rates (Jaber et al 2000). A 
crossover study monitored the effects of NPPV plus either 
heliox (70:30) or oxygen (FiO2 0.30) on gas exchange and 
dyspnea in 19 patients with severe COPD (Jolliet et al 1999). 
The use of heliox decreased PaCO2, reduced dyspnea, and 
favorably changed the breathing pattern of patients. Peak 
inspiratory ﬂ  ow rates were higher, while inspiratory time 
and the ratio of inspiratory time to respiratory cycle length 
were both decreased. All of these ﬁ  ndings suggest a reduced 
work of breathing. A third series of 23 intubated patients with 
COPD and respiratory failure found that the administration 
of heliox signiﬁ  cantly reduced intrinsic PEEP, trapped lung 
volume, and peak and mean airway pressures (Tassaux et al 
2000). Similar ﬁ  ndings were noted in a second small study 
of 12 patients recovering from acute exacerbations of COPD. 
In this randomized prospective crossover trial, heliox de-
creased the resistive work of breathing and intrinsic positive 
end-expiratory pressure (auto-PEEP) without changing the 
breathing pattern (Diehl et al 2003).
One study examined the impact of heliox on pulmonary 
function in ten aging runners with very mild COPD during 
cardiopulmonary exercise testing. Heliox was associated 
with an increase in minute ventilation, in the absence of any 
change in the metabolic cost of breathing (Babb et al 2003). 
Another work studied 12 patients with severe COPD (FEV1 
38[10]% of predicted) comparing heliox (79:21) with air. 
Exercise endurance increased signiﬁ  cantly and peak ventila-
tion time with heliox. This was associated with a signiﬁ  cant 
reduction in lung DH and dyspnea at isotime. The reduction 
in dyspnea correlated signiﬁ  cantly with the increase in IC 
induced by heliox (Palange et al 2004).
Increasing elastic recoil
Although there are no currently available treatments to return 
the lung to its normal structure once it has been damaged by 
the inﬂ  ammatory process (like COPD), this may indeed be 
possible in the future using stem cells (Ortiz et al 2003; Suratt 
et al 2003). Stem cells may indeed improve the compliance 
characteristics of the lung. However, at this time lung volume-
reduction surgery (LVRS; a surgical or bronchoscopic proce-
dure that involves resection or exclusion of the most severely 
affected regions of diseased lung tissue) in patients with diffuse 
emphysema, may improve lung function by increasing elastic International Journal of COPD 2006:1(4) 393
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recoil of the lung, the effective pressure driving maximal 
expiratory ﬂ  ow airway, and the conductance of the airways by 
augmenting the radial traction of their alveolar attachments. 
Hence it may improve ﬂ  ow proportionately at all areas of the 
lung and secondarily reduce hyperinﬂ  ation (Brantigan et al 
1959; Rogers et al 1968; Fessler and Permutt 1998; Ingenito 
et al 2001). This surgery was initially described in the late 
1950s (Brantigan et al 1959). The persistent air leaks that 
limited early success have been diminished considerably by 
the recent surgical advances, which has increased interest in 
this procedure and led to its greater availability (Wakabayashi 
et al 1991; Cooper et al 1995; Keenan et al 1996; Hazelrigg 
et al 1997; Brenner et al 2004).
Several randomized trials have compared LVRS with 
optimal medical treatment (Geddes et al 2000; Fishman et al 
2003; Miller, Berger, et al 2005) and by far the largest of 
these was the National Emphysema Treatment Trial (NETT) 
(Fishman et al 2003). NETT enrolled over 1200 patients 
with severe emphysema who underwent baseline assess-
ment followed by six months of mandatory pulmonary 
rehabilitation. The patients were then randomly assigned 
to surgical or continued medical therapy, with plans for 
three-year follow-up. In this study high risk patients were 
deﬁ  ned as having: FEV1 < 20% and either diffusing capacity 
of the lung for carbon monoxide (DLCO) <  20% predicted 
or homogeneous changes on chest computer tomography 
(Table 3). The 30-day mortality was 16% in the surgical 
group compared with no deaths in the medically managed 
group (NETT 2001). In the remainder of the study, while 
there was a signiﬁ  cant improvement in exercise capacity 
in the surgical group (the same has been found in another 
study [Dolmage et al 2004]), there was no difference in the 
total mortality rate at the end of follow-up with surgical or 
medical therapy (9% vs 10% per year with medical therapy), 
however, the 90-day mortality was signiﬁ  cantly higher with 
surgery (5.2% vs 1.5%) (Fishman et al 2003). Only the subset 
of patients with upper lobe predominant emphysema and low 
exercise capacity (24%) had a signiﬁ  cant reduction in total 
mortality with surgery (7% vs 15% per year, risk ratio 0.47). 
In this study, low exercise capacity was deﬁ  ned as less than 
40% of the gender–speciﬁ  c predicted work rate (40 W in 
men and 25 W in women) (Fishman et al 2003). 
Recently LVRS has been attempted by bronchoscopically 
placing one-way valves in airways associated with areas of 
severe emphysema and hyperexpansion. These valves allow 
air and secretions to move from alveoli to the central airways, 
but prevent air from entering the distal airspaces. Over time, 
this results in collapse of the affected regions. Experience in 
humans is limited, but one series of 19 patients who under-
went unilateral valve placement noted decreased air-trapping 
and improvement in exercise tolerance one month after the 
procedure (Hopkinson et al 2005). 
LVRS produces less functional improvement than lung 
transplant (Gaissert et al 1996), but since patients who undergo 
LVRS are not automatically excluded from receiving a sub-
sequent lung transplant both treatments might be sequentially 
applied (Nathan et al 2004).
Large bullae which can potentially beneﬁ  t from surgical 
resection are uncommon clinically. An important challenge 
for the clinician is to select the patient for bullectomy who 
can have the greatest beneﬁ  t with the lowest morbidity and 
mortality. The most common indication for bullectomy is 
severe dyspnea in the setting of a large bulla occupying at 
least 30%–50% of the hemithorax. Another indication is 
history of a pneumothorax. The physiologic outcome after 
surgery is determined largely by the size of the bulla and 
the severity of the underlying emphysema, and patients with 
severe generalized emphysema tend to do poorly (Nickoladze 
1992). The surgical risk is increased when the FEV1 is less 
than 40% of predicted, and the presence of severe dyspnea, 
a markedly reduced FEV1, hypercapnia, or cor pulmonale 
makes the risk of surgery almost prohibitive (Gunstensen 
and McCormack 1973).
Relieving the inspiratory threshold 
load
Pursed-lip breathing 
We have reviewed the effects of PLB above. In addition to 
reducing respiratory rate, it likely reduces dynamic airways 
compression by generating an extratoracic resistance and thus 
creates PEEP.
Table 3 Subjects likely to beneﬁ  t for lung volume surgery
Marked disability after rehabilitation 
(peak work rate <40% predicted)
Quit from smoking at least 6 month before
Understanding of risks and beneﬁ  ts
Heterogeneous enphysiema 
Marked hyperinﬂ  ation
DLCO <50% >20% as percent of predicted
FEV1 < 35% >20% as percent of predicted
Normal ejection fraction
Abbreviations: DLCO, diffusing capacity of the lung for carbon monoxide; 
FEV, forced expiratory volume in one secondInternational Journal of COPD 2006:1(4) 394
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Positive end-expiratory pressure
Intrinsic PEEP is frequent in mechanically ventilated patients 
with obstructive airways disease. Several studies indicate that 
in patients with ﬂ  ow limitation by dynamic airway collapse, the 
application of small amounts of external PEEP can be beneﬁ  cial 
since intrinsic PEEP can account for about one-third of the total 
work of breathing (Coussa et al 1993). Hyperinﬂ  ation may not 
be affected when applied PEEP is below 85% of the measured 
auto-PEEP (Ranieri et al 1993), however not all patients with 
auto-PEEP and DH have expiratory ﬂ  ow limitation (Armaga-
nidis et al 2000) and care has to be taken to reduce the impact 
of a narrow diameter or kinked endotracheal tube, inspisated 
secretions, exhalation/PEEP valves, and asynchrony due to pain 
or agitation. The incidence of expiratory ﬂ  ow limitation has 
been reported to be as high as 93% upon initiation of mechani-
cal ventilation, but it is reduced by half over time with therapy 
(Alvisi et al 2003). It seems to be more likely when patients are 
supine instead of semirecumbent (Valta et al 1994).
A recent meta-analysis of 7 studies including a total of 
65 patients with COPD shows a modest beneﬁ  cial effect of 
ventilatory support on exercise tolerance as well (van ‘t Hul 
et al 2002), probably in part because continuous positive 
airway pressure (CPAP) unloads inspiratory muscles from 
the inspiratory threshold load imposed by intrinsic PEEP 
(Pepe and Marini 1982; Haluszka et al 1990; Petrof et al 
1990; Lougheed et al 1995). In severe COPD patients CPAP 
of 0.5kPa resulted in a signiﬁ  cant reduction in dyspnea and 
an increase in exercise endurance time (O’Donnell, Sanii, 
Giesbrecht, et al 1988; O’Donnell, Sanii, Younes, et al 1988), 
however excessive CPAP increases the perception of breathing 
effort (O’Donnell, Sanii, Giesbrecht, et al 1988) and hence it 
should be titrated individually. Inspiratory pressure support 
(IPS) a form of pressure-targeted mechanical ventilation which 
each breath is patient triggered and supported has been shown 
to improve exercise tolerance (Keilty et al 1994; Maltais et al 
1995; Kyroussis et al 2000; Polkey et al 2000; van’t Hul et al 
2004) and reduce lactate production (Polkey et al 2000). 
Proportional assisted ventilation, a mode of partial ventilatory 
assistance adapted to the intensity and timing of spontaneous 
ventilatory pattern by providing inspiratory pressure in pro-
portion to a patient’s spontaneous effort, has been shown also 
to increase exercise tolerance (Dolmage and Goldstein 1997; 
Bianchi et al 1998). The role of pressure support in severely 
limited COPD patients is not yet clear. In a recent double-blind 
controlled study of 29 patients with moderate-severe COPD 
and ventilatory limitation during an incremental exercise test, 
37 patients were exercised with either IPS 1kPa (19 subjects) 
versus 0.5kPa (18 subjects) in the control group. Statistically 
signiﬁ  cant differences were found in favor of the IPS in shuttle 
walking distance, cycle endurance, and reduction in minute 
ventilation during exercise (van’t Hul et al 2004).
Measuring ﬂ  ow limitation and 
dynamic hyperinﬂ  ation
Spirometry
Spirometry is a central parameter in the diagnosis and staging 
of COPD, yet it is poorly correlated with dyspnea and exercise 
capacity (Hay et al 1992; Bauerle et al 1998) and has limited 
individual value to predict the increase in exercise tolerance in 
patients with severe COPD (Tobin et al 1984; O’Donnell et al 
1998), however resting IC seems to be better index of exercise 
capacity (Diaz et al 2000) and changes in IC are better indicator 
of the reduction of dyspnea and exercise tolerance (Ramirez-
Venegas et al 1997; Hadcroft and Calverley 2001; Boni et al 
2002; Celli et al 2003; O’Donnell, Fluge, et al 2004; Stevenson 
et al 2005), furthermore the use of IC as an adjunct criterion for 
a bronchodilator test apparently increases the sensitivity to detect 
functional changes clinically relevant (Newton et al 2002; Parker 
et al 2005). Although there is no deﬁ  ned criterion to evaluate 
changes in IC (Pellegrino et al 2005), changes after bronchodila-
tors have been usually larger than 15% (Ramirez-Venegas et al 
1997; Hadcroft and Calverley 2001; Boni et al 2002; Celli et al 
2003; O’Donnell, Fluge, et al 2004). Other useful indexes of air 
trapping are FRC, RV, and their relationship with TLC (Diez 
Herranz 1995), although they are more complex to obtain and 
not as widely available as spirometry.
Flow volume loops
The conventional method used to detect expiratory ﬂ  ow limi-
tation using tidal breathing was one proposed by Hyatt and 
Wilcox (1963). It consists of superimposing a ﬂ  ow–volume 
loop of a tidal breath within a maximum ﬂ  ow–volume curve. 
Expiratory ﬂ  ow limitation is not present when the patient 
breathes below the maximal expiratory ﬂ  ow–volume curve 
(Pride 1999). This method to detect expiratory ﬂ  ow limitation 
has several methodological deﬁ  ciencies such as intrathoracic 
gas compression artefacts (which only can be detected with a 
constant pressure body plethysmograph (Ingram and Schilder 
1966), incorrect alignment of tidal with maximal expiratory 
ﬂ  ow–volume curve considering the TLC as a ﬁ  xed reference 
point, which is not always valid (Younes and Kivinen 1984; International Journal of COPD 2006:1(4) 395
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D’Angelo et al 1993). Respiratory mechanics and the in-
trathoracic pressure swinging are different during the tidal 
and maximal expiratory efforts and exercise may result in 
changes in airways tone (Beck et al 1994). Another important 
limitation of the conventional method is that it requires patient 
cooperation.
The negative expiratory
pressure technique
The negative expiratory pressure technique (NEP) method is 
based on the principle that the increase in pressure caused by 
NEP should result in increased expiratory ﬂ  ow. By contrast, 
in ﬂ  ow-limited subjects, application of NEP should not change 
the expiratory ﬂ  ow (Koulouris et al 1995). For technical details 
we refer the reader elsewhere. This method does not require 
FVC maneuvers, collaboration on the part of the patient, or 
use of a body plethysmograph, and can be used during spon-
taneously breathing subjects during exercise (Calverley and 
Koulouris 2005).
Measurement of dynamic hyperinﬂ  ation 
Since TLC remains essentially unaltered during exercise 
(Stubbing et al 1980; Younes and Kivinen 1984) changes 
in EELV during exercise can be reliably tracked by serial 
IC measurements (Figure 5). Exercise IC measurements are 
reproducible, provided care is taken with their measure-
ment. In one study of 29 patients the variability coefﬁ  cient 
was 17% at rest and approximately 20% during exercise 
with intra-class correlation coefﬁ  cients of 0.77 and 0.73 
respectively (O’Donnell et al 1998). In another study of 15 
patient esophageal pressures were found reproducible during 
IC maneuvers during exercise at different work-rates, the 
reduction in IC during exercise correlates well with esopha-
geal balloon-derived measurements of dynamic compliance 
(O’Donnell, Chau, et al 1997). In another study, three methods 
of measuring IC were tested in 10 severe COPD subjects. IC 
calculated, after correction of the expiratory part of the signal, 
as the difference between the mean EELV of the six breaths 
that preceded the IC prompt and the peak inspiratory volume 
was found to be the most reproducible method (Dolmage and 
Goldstein 2002). In an unpublished multicentric study of 463 
patients with moderate to severe COPD, the intra-class cor-
relation of exercise IC measurements during serial exercise 
tests exceeded 0.85 (O’Donnell, He, et al 2004). The extent 
of the reduction in IC with exercise in COPD is variable. In 
a population of 105 patients with moderate to severe COPD, 
IC at end-exercise was reduced by 20% of its already-reduced 
resting value (O’Donell et al 2001). In another smaller group 
of 27 severe COPD patients a similar reduction was found 
at maximum ventilation at the end of high intensity exercise 
(Puente-Maestu et al 2005). Similar changes were found in 
severe COPD in 15 severe COPD (Yan et al 1997). However, 
guidelines for standardization of IC measurement have not 
yet been issued. Recently a new complex method called opto-
electronic plethysmography has been developed for research 
purposes (Aliverti et al 2004)
Conclusion
Flow limitation and DH are crucial pathophysiological 
mechanisms in the development of exercise intolerance, 
dyspnea, and respiratory failure in COPD patients. As the 
disease advances with progression of symptoms and impair-
ment, the ﬂ  ow limitation and DH proportionally worsens. 
Several methods of treatment may palliate its impact of 
ﬂ  ow limitation and DH on the patient, including physical 
therapy, bronchodilators, ventilatory support, oxygen, heliox, 
or surgery. Measurement of DH may be done indirectly by 
spirometry or by more direct approaches that have known 
limitations or are not widely available. Clinical use is lim-
ited by the lack of a standard method to measure DH or ﬂ  ow 
limitation during exercise.
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